HK1037144A1 - Controlled release composition comprising a sustained release layer and a fast release layer. - Google Patents

Controlled release composition comprising a sustained release layer and a fast release layer.

Info

Publication number
HK1037144A1
HK1037144A1 HK01108103A HK01108103A HK1037144A1 HK 1037144 A1 HK1037144 A1 HK 1037144A1 HK 01108103 A HK01108103 A HK 01108103A HK 01108103 A HK01108103 A HK 01108103A HK 1037144 A1 HK1037144 A1 HK 1037144A1
Authority
HK
Hong Kong
Prior art keywords
release layer
fast
composition
sustained
controlled
Prior art date
Application number
HK01108103A
Other languages
English (en)
Inventor
Sun Y Lin
Lorraine L Wearley
Dilip J Gole
Gary W Possage
Paul K Wilkinson
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of HK1037144A1 publication Critical patent/HK1037144A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
HK01108103A 1999-12-23 2001-11-16 Controlled release composition comprising a sustained release layer and a fast release layer. HK1037144A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47182599A 1999-12-23 1999-12-23

Publications (1)

Publication Number Publication Date
HK1037144A1 true HK1037144A1 (en) 2003-04-24

Family

ID=23873133

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01108103A HK1037144A1 (en) 1999-12-23 2001-11-16 Controlled release composition comprising a sustained release layer and a fast release layer.

Country Status (14)

Country Link
US (1) US20050074490A1 (fr)
EP (1) EP1110541B1 (fr)
JP (1) JP2001278779A (fr)
KR (1) KR20010057581A (fr)
CN (1) CN1302604A (fr)
AR (1) AR027907A1 (fr)
AU (1) AU7251100A (fr)
BR (1) BR0007360A (fr)
CA (1) CA2329574A1 (fr)
CO (1) CO5251434A1 (fr)
DE (1) DE60015059T2 (fr)
ES (1) ES2228418T3 (fr)
HK (1) HK1037144A1 (fr)
MX (1) MXPA01000121A (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2366794A (en) * 2000-09-13 2002-03-20 Procter & Gamble Process for making a foam component
KR20030006788A (ko) * 2001-07-16 2003-01-23 이승진 치주질환 치료용 서방출성 고분자제제
EP1537880A4 (fr) * 2002-09-11 2009-07-01 Takeda Pharmaceutical Preparation a liberation prolongee
US7959946B2 (en) * 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7037522B2 (en) * 2002-09-27 2006-05-02 Western Holdings, L.L.C. Nocturnal muscle enhancing composition and method
BRPI0414500A (pt) 2003-09-19 2006-11-07 Drugtech Corp formulação farmacêutica composição para tratar uma infecção vaginal, e, métodos para tratar uma infecção vaginal, para estabilizar uma formulação de clindamicina, para tratar ou prevenir uma recorrência de uma infecção vaginal em uma paciente e para tratar condições vaginais
PL1591109T3 (pl) * 2004-04-30 2008-11-28 Topotarget Germany Ag Preparat zawierający inhibitor deacetylazy histonów wykazujący dwufazowe uwalnianie”
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
EP1830886B1 (fr) * 2004-12-27 2016-04-13 Eisai R&D Management Co., Ltd. Methode de stabilisation d'un medicament contre la demence
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
ITFI20050215A1 (it) * 2005-10-13 2007-04-14 Valpharma Internat S P A Composizione nutrizionale a base di amminoacidi
AU2006332520A1 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Drug delivery system for bioadhesion to a vulvovaginal surface
US20070281008A1 (en) * 2006-06-05 2007-12-06 Lin Shun Y Personal lubricant compositions and kits for providing personal lubrication
WO2008081590A1 (fr) * 2006-12-27 2008-07-10 Fujifilm Corporation Composition médicale
US10548839B2 (en) 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
US9545376B2 (en) 2013-01-23 2017-01-17 Arx, Llc Production of unit dose constructs
EP3536313B1 (fr) * 2013-12-31 2022-02-16 Johnson & Johnson Consumer Inc. Procédé de formation d'un produit en forme de film
AU2014374104B2 (en) 2013-12-31 2020-02-20 Johnson & Johnson Consumer Inc. Process for forming a multi layered shaped film
ES2703210T3 (es) 2013-12-31 2019-03-07 Johnson & Johnson Consumer Inc Proceso en un solo paso para la formación de un producto en la forma de película de capas múltiples, producto y aparato
CA3040422A1 (fr) * 2016-10-13 2018-04-19 Catalent U.K. Swindon Zydis Limited Compositions pharmaceutiques lyophilisees pour administration vaginale
US11517533B2 (en) 2016-10-25 2022-12-06 Catalent U.K. Swindon Zydis Limited Compositions of different densities for fast disintegrating multi-layer tablet
BR112020021737A2 (pt) 2018-04-27 2021-01-26 Fresh Inset S.A. composições e artigos compreendendo complexos de 1-metilciclopropeno e alfa-ciclodextrina

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3234091A (en) * 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
DE3212412C2 (de) * 1982-04-02 1986-01-02 Dr. Ruhland Nachf. GmbH, 8425 Neustadt Gewebeverklebbare kollagene Wundauflage
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
US4915953A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering acetaminophen or phenylpropanolamine
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
US5558880A (en) * 1989-12-22 1996-09-24 Janssen Pharmaceutica Inc. Pharmaceutical and other dosage forms
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
CA2105887C (fr) * 1992-09-10 2004-03-16 Peter Britton Dispositif bio-absorbable pour l'administration de composes actifs
US5354558A (en) * 1992-09-10 1994-10-11 Mcneil-Pcc, Inc. Bioerodible contraceptive suppository
EP0804170B1 (fr) * 1993-07-09 2001-11-14 R.P. Scherer Corporation Procede de fabrication de formes galeniques de medicaments lyophilises
US5500227A (en) * 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
GB9421837D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms
US5656283A (en) * 1995-06-08 1997-08-12 Ortho Pharmaceutical Corporation In-situ lyophilization of vaginal suppository in unit dose applicator and resultant product
ATE250929T1 (de) * 1997-05-30 2003-10-15 Osmotica Corp Mehrlagige osmosevorrichtung
EP1003476B1 (fr) * 1997-08-11 2004-12-22 ALZA Corporation Forme galenique d'un agent actif a liberation prolongee adaptee a la retention gastrique
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives

Also Published As

Publication number Publication date
AR027907A1 (es) 2003-04-16
DE60015059T2 (de) 2005-12-15
BR0007360A (pt) 2001-08-14
MXPA01000121A (es) 2002-10-23
AU7251100A (en) 2001-06-28
CO5251434A1 (es) 2003-02-28
US20050074490A1 (en) 2005-04-07
KR20010057581A (ko) 2001-07-04
CN1302604A (zh) 2001-07-11
EP1110541B1 (fr) 2004-10-20
DE60015059D1 (de) 2004-11-25
JP2001278779A (ja) 2001-10-10
CA2329574A1 (fr) 2001-06-23
ES2228418T3 (es) 2005-04-16
EP1110541A1 (fr) 2001-06-27

Similar Documents

Publication Publication Date Title
HK1037144A1 (en) Controlled release composition comprising a sustained release layer and a fast release layer.
EP1152709A4 (fr) Composite a liberation controlee
MXPA01005543A (es) Formulacion de liberacion controlada que consta de gnrh-ii.
GB2363986B (en) Sustained release microparticle and method for preparing the same
MXPA02000725A (es) Formulacion opioide de liberacion sostenida.
AU5805700A (en) Glucoamylase variant
AU3731600A (en) Composition and structures made therefrom
MXPA03005318A (es) Material biaxialmente extendible.
EP1070751A4 (fr) Materiau de friction
EP1071194A4 (fr) Actionneur
GB9911148D0 (en) Actuator
HK1019142A1 (en) Drug composition with controlled drug release rate
EP1143168A4 (fr) Dispositif de commande
ZA9810081B (en) Extended release formulation.
IL148112A (en) Variable release microcapsules
TW499033U (en) Electro-megnatic actuator
ZA200000171B (en) Analgesic with controlled active substance release.
EP1210084A4 (fr) Pyridomorphinanes, thienomorphinanes et utilisation
GB2350659B (en) Actuator
GB0010165D0 (en) Pesticidal composition
AU3732500A (en) Beclin and uses thereof
AU6913100A (en) Notch receptor ligands and uses thereof
AUPP279698A0 (en) Sustained release formulation
GB0019823D0 (en) Helmet layer
GB0010166D0 (en) Pesticidal composition

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111222